Health Canada's drug approval pathways compared to FDA reveal gaps in submission and approval timelines
Comparison in the Use of Regulatory Pathways Between Health Canada and the Food and Drug Administration: A Cross-sectional Study.
Abstract
A cross-sectional study investigated submission and approval timeline disparities for new drugs between Health Canada and the FDA.